Loading…

Hybrid Cell Membrane‐Coated Nanoparticles for Biomedical Applications

There is growing interest in developing cell membrane‐coated nanoparticles (CNPs) for unique host cell mimicry and therapeutic applications. The continuous evolution of this technology has motivated the coating of nanoparticles with hybrid membranes originating from diverse cell types. The resulting...

Full description

Saved in:
Bibliographic Details
Published in:Small structures 2024-05, Vol.5 (5), p.n/a
Main Authors: Yu, Yiyan, Peng, Yifei, Shen, Wei‐Ting, Zhou, Zhidong, Kai, Mingxuan, Gao, Weiwei, Zhang, Liangfang
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4233-3661e1190787e79e696d263ee773e626fadd9a7fcec33e09dc75c6cd3a7566b63
cites cdi_FETCH-LOGICAL-c4233-3661e1190787e79e696d263ee773e626fadd9a7fcec33e09dc75c6cd3a7566b63
container_end_page n/a
container_issue 5
container_start_page
container_title Small structures
container_volume 5
creator Yu, Yiyan
Peng, Yifei
Shen, Wei‐Ting
Zhou, Zhidong
Kai, Mingxuan
Gao, Weiwei
Zhang, Liangfang
description There is growing interest in developing cell membrane‐coated nanoparticles (CNPs) for unique host cell mimicry and therapeutic applications. The continuous evolution of this technology has motivated the coating of nanoparticles with hybrid membranes originating from diverse cell types. The resulting hybrid cell membrane‐coated nanoparticles (hybrid CNPs) exhibit a higher level of synergy among multifunctionalities with better multitasking capabilities than their monotypic membrane‐coated counterparts. This advancement has catalyzed the initiation of numerous research opportunities, marking the advent of a promising frontier in therapeutic applications. This review outlines emerging biomedical applications of hybrid CNPs, focusing on drug targeting, immune modulation, biological neutralization, and disease diagnosis. Within each application, the review underscores how the strategic hybridization of distinct cell membranes augments the resulting nanoparticle therapeutic efficacy. Overall, the insights presented herein consolidate our understanding of current applications and may inspire novel designs with new biomedical applications. This review summarizes recent advancements in developing hybrid cell membrane‐coated nanoparticles (hybrid CNPs), emphasizing their growing applications in drug targeting, immune modulation, biological neutralization, and disease diagnosis. The unique functions resulting from membrane hybridization in each hybrid CNP design are highlighted, and the future perspectives of hybrid CNPs are discussed.
doi_str_mv 10.1002/sstr.202300473
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_2a5434fe130149c88f22ece5522038f2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_2a5434fe130149c88f22ece5522038f2</doaj_id><sourcerecordid>3051765858</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4233-3661e1190787e79e696d263ee773e626fadd9a7fcec33e09dc75c6cd3a7566b63</originalsourceid><addsrcrecordid>eNqFUMtOwzAQjBBIVKVXzpE4p_gR2_GxRNBWKiDRcrZce4NSpXGwU6He-AS-kS8hJahw47Szq5nZ0UTRJUZjjBC5DqH1Y4IIRSgV9CQaEJ5lSYo4Of2Dz6NRCBvUCRjGQopBNJ3t1760cQ5VFd_Ddu11DZ_vH7nTLdj4Qdeu0b4tTQUhLpyPb0q3BVsaXcWTpqk60JauDhfRWaGrAKOfOYye725X-SxZPE7n-WSRmJRQmlDOMWAskcgECAlccks4BRCCAie80NZKLQoDhlJA0hrBDDeWasE4X3M6jOa9r3V6oxpfbrXfK6dL9X1w_kX9xFVEs5SmBWCKcCpNlhWEgAHGCEG0Wzqvq96r8e51B6FVG7fzdRdfUcSw4CxjWcca9yzjXQgeiuNXjNShe3XoXh277wSyF7yVFez_YavlcvX0q_0CxteH6Q</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3051765858</pqid></control><display><type>article</type><title>Hybrid Cell Membrane‐Coated Nanoparticles for Biomedical Applications</title><source>Wiley Open Access</source><creator>Yu, Yiyan ; Peng, Yifei ; Shen, Wei‐Ting ; Zhou, Zhidong ; Kai, Mingxuan ; Gao, Weiwei ; Zhang, Liangfang</creator><creatorcontrib>Yu, Yiyan ; Peng, Yifei ; Shen, Wei‐Ting ; Zhou, Zhidong ; Kai, Mingxuan ; Gao, Weiwei ; Zhang, Liangfang</creatorcontrib><description>There is growing interest in developing cell membrane‐coated nanoparticles (CNPs) for unique host cell mimicry and therapeutic applications. The continuous evolution of this technology has motivated the coating of nanoparticles with hybrid membranes originating from diverse cell types. The resulting hybrid cell membrane‐coated nanoparticles (hybrid CNPs) exhibit a higher level of synergy among multifunctionalities with better multitasking capabilities than their monotypic membrane‐coated counterparts. This advancement has catalyzed the initiation of numerous research opportunities, marking the advent of a promising frontier in therapeutic applications. This review outlines emerging biomedical applications of hybrid CNPs, focusing on drug targeting, immune modulation, biological neutralization, and disease diagnosis. Within each application, the review underscores how the strategic hybridization of distinct cell membranes augments the resulting nanoparticle therapeutic efficacy. Overall, the insights presented herein consolidate our understanding of current applications and may inspire novel designs with new biomedical applications. This review summarizes recent advancements in developing hybrid cell membrane‐coated nanoparticles (hybrid CNPs), emphasizing their growing applications in drug targeting, immune modulation, biological neutralization, and disease diagnosis. The unique functions resulting from membrane hybridization in each hybrid CNP design are highlighted, and the future perspectives of hybrid CNPs are discussed.</description><identifier>ISSN: 2688-4062</identifier><identifier>EISSN: 2688-4062</identifier><identifier>DOI: 10.1002/sstr.202300473</identifier><language>eng</language><publisher>Weinheim: John Wiley &amp; Sons, Inc</publisher><subject>Biomedical materials ; cell membrane coatings ; Cell membranes ; hybrid membranes ; Mimicry ; Multitasking ; nanomedicines ; Nanoparticles ; nanotechnologies</subject><ispartof>Small structures, 2024-05, Vol.5 (5), p.n/a</ispartof><rights>2024 The Authors. Small Structures published by Wiley‐VCH GmbH</rights><rights>2024. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4233-3661e1190787e79e696d263ee773e626fadd9a7fcec33e09dc75c6cd3a7566b63</citedby><cites>FETCH-LOGICAL-c4233-3661e1190787e79e696d263ee773e626fadd9a7fcec33e09dc75c6cd3a7566b63</cites><orcidid>0000-0003-0637-0654</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fsstr.202300473$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fsstr.202300473$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,11542,27903,27904,46030,46454</link.rule.ids></links><search><creatorcontrib>Yu, Yiyan</creatorcontrib><creatorcontrib>Peng, Yifei</creatorcontrib><creatorcontrib>Shen, Wei‐Ting</creatorcontrib><creatorcontrib>Zhou, Zhidong</creatorcontrib><creatorcontrib>Kai, Mingxuan</creatorcontrib><creatorcontrib>Gao, Weiwei</creatorcontrib><creatorcontrib>Zhang, Liangfang</creatorcontrib><title>Hybrid Cell Membrane‐Coated Nanoparticles for Biomedical Applications</title><title>Small structures</title><description>There is growing interest in developing cell membrane‐coated nanoparticles (CNPs) for unique host cell mimicry and therapeutic applications. The continuous evolution of this technology has motivated the coating of nanoparticles with hybrid membranes originating from diverse cell types. The resulting hybrid cell membrane‐coated nanoparticles (hybrid CNPs) exhibit a higher level of synergy among multifunctionalities with better multitasking capabilities than their monotypic membrane‐coated counterparts. This advancement has catalyzed the initiation of numerous research opportunities, marking the advent of a promising frontier in therapeutic applications. This review outlines emerging biomedical applications of hybrid CNPs, focusing on drug targeting, immune modulation, biological neutralization, and disease diagnosis. Within each application, the review underscores how the strategic hybridization of distinct cell membranes augments the resulting nanoparticle therapeutic efficacy. Overall, the insights presented herein consolidate our understanding of current applications and may inspire novel designs with new biomedical applications. This review summarizes recent advancements in developing hybrid cell membrane‐coated nanoparticles (hybrid CNPs), emphasizing their growing applications in drug targeting, immune modulation, biological neutralization, and disease diagnosis. The unique functions resulting from membrane hybridization in each hybrid CNP design are highlighted, and the future perspectives of hybrid CNPs are discussed.</description><subject>Biomedical materials</subject><subject>cell membrane coatings</subject><subject>Cell membranes</subject><subject>hybrid membranes</subject><subject>Mimicry</subject><subject>Multitasking</subject><subject>nanomedicines</subject><subject>Nanoparticles</subject><subject>nanotechnologies</subject><issn>2688-4062</issn><issn>2688-4062</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>DOA</sourceid><recordid>eNqFUMtOwzAQjBBIVKVXzpE4p_gR2_GxRNBWKiDRcrZce4NSpXGwU6He-AS-kS8hJahw47Szq5nZ0UTRJUZjjBC5DqH1Y4IIRSgV9CQaEJ5lSYo4Of2Dz6NRCBvUCRjGQopBNJ3t1760cQ5VFd_Ddu11DZ_vH7nTLdj4Qdeu0b4tTQUhLpyPb0q3BVsaXcWTpqk60JauDhfRWaGrAKOfOYye725X-SxZPE7n-WSRmJRQmlDOMWAskcgECAlccks4BRCCAie80NZKLQoDhlJA0hrBDDeWasE4X3M6jOa9r3V6oxpfbrXfK6dL9X1w_kX9xFVEs5SmBWCKcCpNlhWEgAHGCEG0Wzqvq96r8e51B6FVG7fzdRdfUcSw4CxjWcca9yzjXQgeiuNXjNShe3XoXh277wSyF7yVFez_YavlcvX0q_0CxteH6Q</recordid><startdate>202405</startdate><enddate>202405</enddate><creator>Yu, Yiyan</creator><creator>Peng, Yifei</creator><creator>Shen, Wei‐Ting</creator><creator>Zhou, Zhidong</creator><creator>Kai, Mingxuan</creator><creator>Gao, Weiwei</creator><creator>Zhang, Liangfang</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley-VCH</general><scope>24P</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SR</scope><scope>8FD</scope><scope>JG9</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-0637-0654</orcidid></search><sort><creationdate>202405</creationdate><title>Hybrid Cell Membrane‐Coated Nanoparticles for Biomedical Applications</title><author>Yu, Yiyan ; Peng, Yifei ; Shen, Wei‐Ting ; Zhou, Zhidong ; Kai, Mingxuan ; Gao, Weiwei ; Zhang, Liangfang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4233-3661e1190787e79e696d263ee773e626fadd9a7fcec33e09dc75c6cd3a7566b63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Biomedical materials</topic><topic>cell membrane coatings</topic><topic>Cell membranes</topic><topic>hybrid membranes</topic><topic>Mimicry</topic><topic>Multitasking</topic><topic>nanomedicines</topic><topic>Nanoparticles</topic><topic>nanotechnologies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yu, Yiyan</creatorcontrib><creatorcontrib>Peng, Yifei</creatorcontrib><creatorcontrib>Shen, Wei‐Ting</creatorcontrib><creatorcontrib>Zhou, Zhidong</creatorcontrib><creatorcontrib>Kai, Mingxuan</creatorcontrib><creatorcontrib>Gao, Weiwei</creatorcontrib><creatorcontrib>Zhang, Liangfang</creatorcontrib><collection>Wiley Open Access</collection><collection>CrossRef</collection><collection>Engineered Materials Abstracts</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Small structures</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yu, Yiyan</au><au>Peng, Yifei</au><au>Shen, Wei‐Ting</au><au>Zhou, Zhidong</au><au>Kai, Mingxuan</au><au>Gao, Weiwei</au><au>Zhang, Liangfang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hybrid Cell Membrane‐Coated Nanoparticles for Biomedical Applications</atitle><jtitle>Small structures</jtitle><date>2024-05</date><risdate>2024</risdate><volume>5</volume><issue>5</issue><epage>n/a</epage><issn>2688-4062</issn><eissn>2688-4062</eissn><abstract>There is growing interest in developing cell membrane‐coated nanoparticles (CNPs) for unique host cell mimicry and therapeutic applications. The continuous evolution of this technology has motivated the coating of nanoparticles with hybrid membranes originating from diverse cell types. The resulting hybrid cell membrane‐coated nanoparticles (hybrid CNPs) exhibit a higher level of synergy among multifunctionalities with better multitasking capabilities than their monotypic membrane‐coated counterparts. This advancement has catalyzed the initiation of numerous research opportunities, marking the advent of a promising frontier in therapeutic applications. This review outlines emerging biomedical applications of hybrid CNPs, focusing on drug targeting, immune modulation, biological neutralization, and disease diagnosis. Within each application, the review underscores how the strategic hybridization of distinct cell membranes augments the resulting nanoparticle therapeutic efficacy. Overall, the insights presented herein consolidate our understanding of current applications and may inspire novel designs with new biomedical applications. This review summarizes recent advancements in developing hybrid cell membrane‐coated nanoparticles (hybrid CNPs), emphasizing their growing applications in drug targeting, immune modulation, biological neutralization, and disease diagnosis. The unique functions resulting from membrane hybridization in each hybrid CNP design are highlighted, and the future perspectives of hybrid CNPs are discussed.</abstract><cop>Weinheim</cop><pub>John Wiley &amp; Sons, Inc</pub><doi>10.1002/sstr.202300473</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0003-0637-0654</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2688-4062
ispartof Small structures, 2024-05, Vol.5 (5), p.n/a
issn 2688-4062
2688-4062
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_2a5434fe130149c88f22ece5522038f2
source Wiley Open Access
subjects Biomedical materials
cell membrane coatings
Cell membranes
hybrid membranes
Mimicry
Multitasking
nanomedicines
Nanoparticles
nanotechnologies
title Hybrid Cell Membrane‐Coated Nanoparticles for Biomedical Applications
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T22%3A45%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hybrid%20Cell%20Membrane%E2%80%90Coated%20Nanoparticles%20for%20Biomedical%20Applications&rft.jtitle=Small%20structures&rft.au=Yu,%20Yiyan&rft.date=2024-05&rft.volume=5&rft.issue=5&rft.epage=n/a&rft.issn=2688-4062&rft.eissn=2688-4062&rft_id=info:doi/10.1002/sstr.202300473&rft_dat=%3Cproquest_doaj_%3E3051765858%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4233-3661e1190787e79e696d263ee773e626fadd9a7fcec33e09dc75c6cd3a7566b63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3051765858&rft_id=info:pmid/&rfr_iscdi=true